Benjamin Purow is a Neurology physician affiliated with University of Virginia Health System. OpenAlex indexes 220 publications with 10,218 citations (h-index 41); ClinicalTrials.gov lists 1 registered study matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
1240 Lee St
Charlottesville, VA 229080001
Telephone
434-924-9333Provider last certified this registry record 9 Aug 2023.
Clinical trials
- Stereotactic Radiosurgery With Nivolumab and Valproate in Patients With Recurrent Glioblastoma
Sponsor: University of Virginia
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Metabolism & gastrointestinal
47.8%Serotonin-3 Receptor Antagonist24.6%Ondansetron Hcl100%Part D<11 patientsNicotinic Acid23.2%Niacin Er100%Part D<11 patientsSensory organs
31.9%Corticosteroid31.9%Dexamethasone100%Part D<11 patientsAnti-infectives
20.3%Short-acting sulfonamides20.3%Sulfamethoxazole-Trimethoprim100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
8 NIH research awards on record, funded 2008–2026 per NIH RePORTER. The latest:
- Novel immunotherapeutic potential of DGKalpha inhibition for glioblastoma
University of Virginia
FY2026$398,997R01NS126265
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Similar KOLs
Other experts from the same institution or the same specialty.
Linda Duska, MD
University of Virginia Health System
Kenneth Bilchick, MD
University of Virginia Health System
Mark Stoler, MD
University of Virginia Health System
Irving Kron, MD
University of Virginia Health System
Bruce Miller, MD
University of California, San Francisco (UCSF)
Bradley Boeve, MD
Mayo Clinic
Richard Lipton, MD
Albert Einstein College of Medicine
Steven Dekosky, MD
University of Florida Health
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”